NCT03349996View on ClinicalTrials.gov

Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

October 21, 2020

Study Completion Date

January 15, 2025

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

LifeStream Peripheral Stent Graft System

Patients will be treated with the LifeStream Peripheral Stent Graft System

Trial Locations (7)

2060

Z.N.A., Antwerp

2820

Imelda Hospital, Bonheiden

3300

R.Z. Heilig Hart, Tienen

3600

Z.O.L., Genk

8500

Az Groeninge, Kortrijk

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT03349996 - Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions | Biotech Hunter | Biotech Hunter